TD Securities upgraded shares of Extendicare (TSE:EXE – Free Report) from a hold rating to a buy rating in a research note issued to investors on Monday morning, MarketBeat reports. TD Securities currently has C$32.00 price objective on the stock, up from their previous price objective of C$19.00.
Other analysts have also recently issued reports about the stock. National Bank Financial upped their target price on shares of Extendicare from C$24.50 to C$29.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Canadian Imperial Bank of Commerce upped their target price on shares of Extendicare from C$22.00 to C$32.00 in a report on Thursday, April 2nd. Finally, BMO Capital Markets upped their target price on shares of Extendicare from C$24.00 to C$30.00 in a report on Monday, March 2nd. One investment analyst has rated the stock with a Strong Buy rating and four have given a Buy rating to the stock. According to MarketBeat, Extendicare presently has a consensus rating of “Buy” and an average target price of C$28.64.
Get Our Latest Analysis on EXE
Extendicare Stock Up 1.7%
Extendicare (TSE:EXE – Get Free Report) last announced its earnings results on Thursday, February 26th. The company reported C$0.29 EPS for the quarter. Extendicare had a net margin of 5.82% and a return on equity of 47.65%. The business had revenue of C$462.03 million during the quarter. Research analysts anticipate that Extendicare will post 0.6134729 EPS for the current year.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
